GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)
GeneDx Holdings (WGS) posted quarterly Preferred Stock Liabilities of $334.4 million for Q2 2021, up 54.04% YoY from $217.1 million in Q2 2020, and little changed sequentially from $334.4 million in Q1 2021.
GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
GeneDx Holdings has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $334.4 million for Q2 2021.
- In Q2 2021, Preferred Stock Liabilities rose 54.04% year-over-year to $334.4 million; the TTM figure through Jun 2021 stood at $334.4 million (up 54.04% YoY), while the FY2020 annual figure was $334.4 million, up 54.04% from the prior year.
- Preferred Stock Liabilities was little changed at $334.4 million in Q2 2021, from $334.4 million in the prior quarter.
- Over the last five years, Preferred Stock Liabilities for WGS reached as high as $334.4 million in Q3 2020 and fell as low as $217.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | GeneDx Holdings | 2.10 Bn | 1.93 Bn | 68.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 334.44 Mn |
| Mar 31, 2021 | 334.44 Mn |
| Dec 31, 2020 | 334.44 Mn |
| Sep 30, 2020 | 334.44 Mn |
| Jun 30, 2020 | 217.12 Mn |